- Page 2 and 3: Herbal and Traditional Medicine Mol
- Page 4: Related Volumes Vitamin E in Health
- Page 8 and 9: Although great care has been taken
- Page 10 and 11: iv Series Introduction Normal metab
- Page 14 and 15: viii Preface National Center for Co
- Page 16 and 17: x 5. Effects of Phytochemicals in C
- Page 18 and 19: xii 32. Phytochemistry, Pharmacolog
- Page 20 and 21: xiv Contributors Iris F. F. Benzie,
- Page 22 and 23: xvi Contributors Rene´ e J. Grayer
- Page 24 and 25: xviii Contributors Hiroshi Nishida,
- Page 26 and 27: xx Contributors Sissi Wachtel-Galor
- Page 28 and 29: 2 Bodeker In this chapter, an attem
- Page 30 and 31: 4 Bodeker IV. A POLICY FRAMEWORK Wi
- Page 32 and 33: 6 Bodeker medicines with an establi
- Page 34 and 35: 8 Bodeker 3. Disputes over patents
- Page 36 and 37: 10 Bodeker medical insurers now rou
- Page 38 and 39: 12 Bodeker High profitability of tr
- Page 40 and 41: 14 Bodeker icum, may be better tole
- Page 42 and 43: 16 Bodeker mentary Health Systems a
- Page 44 and 45: 18 Bodeker The duration of the toxi
- Page 46 and 47: 20 Postmarket regulatory activity c
- Page 48 and 49: 22 Provision of information/trainin
- Page 50 and 51: 24 Bodeker In view of these trends,
- Page 52 and 53: 26 Bodeker vestigate such issues as
- Page 54 and 55: 28 Bodeker 4. RCTSs are a powerful
- Page 56 and 57: 30 Bodeker Chaudhury R, Bodeker G.
- Page 59 and 60: 2 Can Traditional Medicine Coexist
- Page 61 and 62: Can Traditional and Modern Medicine
- Page 63 and 64:
Can Traditional and Modern Medicine
- Page 65 and 66:
Can Traditional and Modern Medicine
- Page 67 and 68:
Can Traditional and Modern Medicine
- Page 69 and 70:
Can Traditional and Modern Medicine
- Page 71 and 72:
Can Traditional and Modern Medicine
- Page 73 and 74:
Can Traditional and Modern Medicine
- Page 75 and 76:
Can Traditional and Modern Medicine
- Page 77 and 78:
Can Traditional and Modern Medicine
- Page 79 and 80:
3 Clinical Trials for Herbal Extrac
- Page 81 and 82:
Clinical Trials for Herbal Extracts
- Page 83 and 84:
Clinical Trials for Herbal Extracts
- Page 85 and 86:
Clinical Trials for Herbal Extracts
- Page 87 and 88:
Clinical Trials for Herbal Extracts
- Page 89 and 90:
Clinical Trials for Herbal Extracts
- Page 91 and 92:
Clinical Trials for Herbal Extracts
- Page 93 and 94:
Clinical Trials for Herbal Extracts
- Page 95 and 96:
Clinical Trials for Herbal Extracts
- Page 97 and 98:
Clinical Trials for Herbal Extracts
- Page 99 and 100:
4 Herbal Medicine Criteria for Use
- Page 101 and 102:
Criteria for Use of Herbal Medicine
- Page 103 and 104:
Criteria for Use of Herbal Medicine
- Page 105 and 106:
Criteria for Use of Herbal Medicine
- Page 107 and 108:
Criteria for Use of Herbal Medicine
- Page 109 and 110:
Criteria for Use of Herbal Medicine
- Page 111 and 112:
Criteria for Use of Herbal Medicine
- Page 113 and 114:
5 Effects of Phytochemicals in Chin
- Page 115 and 116:
Phytochemicals in CFI and Gut Healt
- Page 117 and 118:
Phytochemicals in CFI and Gut Healt
- Page 119 and 120:
Phytochemicals in CFI and Gut Healt
- Page 121 and 122:
Phytochemicals in CFI and Gut Healt
- Page 123 and 124:
Phytochemicals in CFI and Gut Healt
- Page 125 and 126:
Phytochemicals in CFI and Gut Healt
- Page 127 and 128:
Phytochemicals in CFI and Gut Healt
- Page 129 and 130:
Phytochemicals in CFI and Gut Healt
- Page 131 and 132:
Phytochemicals in CFI and Gut Healt
- Page 133 and 134:
Phytochemicals in CFI and Gut Healt
- Page 135 and 136:
Phytochemicals in CFI and Gut Healt
- Page 137 and 138:
Phytochemicals in CFI and Gut Healt
- Page 139 and 140:
Phytochemicals in CFI and Gut Healt
- Page 141:
Phytochemicals in CFI and Gut Healt
- Page 144 and 145:
118 Weisburger C. Heterocyclic Arom
- Page 146 and 147:
120 about 25-35 min, an intermediat
- Page 148 and 149:
TABLE 3 Effect of Tea-Derived Polyp
- Page 150 and 151:
124 TABLE 5 MNU-induced Colon Tumor
- Page 152 and 153:
126 TABLE 7 UDP-GT Activity in Live
- Page 154 and 155:
TABLE 9 Effect of PO Administration
- Page 156 and 157:
130 utilized the tritiated chemical
- Page 158 and 159:
132 and calcium metabolism and effe
- Page 160 and 161:
134 modify host enzyme systems serv
- Page 162 and 163:
136 Weisburger 21. Vinson JA. Black
- Page 164 and 165:
138 Weisburger 52. Orner GA, Dashwo
- Page 166 and 167:
140 Weisburger through mitotic sign
- Page 168 and 169:
142 Weisburger multiple-dose admini
- Page 170 and 171:
144 Weisburger 140. Valcic S, Timme
- Page 172 and 173:
146 Christen FIGURE 1 Number of pub
- Page 174 and 175:
148 Christen of the leaves. This sp
- Page 176 and 177:
150 TABLE 1 Main Effects of Ginkgo
- Page 178 and 179:
152 TABLE 1 Continued Clinical tria
- Page 180 and 181:
154 Christen experimental data have
- Page 182 and 183:
156 Christen cifically against them
- Page 184 and 185:
158 Christen recovery workers: anti
- Page 186 and 187:
160 Christen Mazziotta JC, Small GW
- Page 188 and 189:
162 Christen 68. Paasche G, Huster
- Page 190 and 191:
164 Christen Ginkgo biloba (EGb 761
- Page 192 and 193:
166 establish the safety and effica
- Page 194 and 195:
168 Bode and Dong activity in vivo
- Page 196 and 197:
170 Bode and Dong showed that ginge
- Page 198 and 199:
172 inhibited platelet aggregation
- Page 200 and 201:
174 Bode and Dong 26. Ahmed RS, Set
- Page 202 and 203:
176 Bode and Dong 58. Jewell D, You
- Page 205 and 206:
9 Lingzhi Polyphorous Fungus (Ganod
- Page 207 and 208:
Lingzhi Polyphorous Fungus (Ganoder
- Page 209 and 210:
Lingzhi Polyphorous Fungus (Ganoder
- Page 211 and 212:
Lingzhi Polyphorous Fungus (Ganoder
- Page 213 and 214:
Lingzhi Polyphorous Fungus (Ganoder
- Page 215 and 216:
Lingzhi Polyphorous Fungus (Ganoder
- Page 217 and 218:
Lingzhi Polyphorous Fungus (Ganoder
- Page 219 and 220:
Lingzhi Polyphorous Fungus (Ganoder
- Page 221 and 222:
Lingzhi Polyphorous Fungus (Ganoder
- Page 223 and 224:
Lingzhi Polyphorous Fungus (Ganoder
- Page 225 and 226:
Lingzhi Polyphorous Fungus (Ganoder
- Page 227 and 228:
Lingzhi Polyphorous Fungus (Ganoder
- Page 229 and 230:
Lingzhi Polyphorous Fungus (Ganoder
- Page 231 and 232:
Lingzhi Polyphorous Fungus (Ganoder
- Page 233 and 234:
Lingzhi Polyphorous Fungus (Ganoder
- Page 235 and 236:
Lingzhi Polyphorous Fungus (Ganoder
- Page 237 and 238:
Lingzhi Polyphorous Fungus (Ganoder
- Page 239 and 240:
Lingzhi Polyphorous Fungus (Ganoder
- Page 241 and 242:
Lingzhi Polyphorous Fungus (Ganoder
- Page 243 and 244:
Lingzhi Polyphorous Fungus (Ganoder
- Page 245 and 246:
Lingzhi Polyphorous Fungus (Ganoder
- Page 247 and 248:
Lingzhi Polyphorous Fungus (Ganoder
- Page 249 and 250:
Lingzhi Polyphorous Fungus (Ganoder
- Page 251 and 252:
Lingzhi Polyphorous Fungus (Ganoder
- Page 253 and 254:
Lingzhi Polyphorous Fungus (Ganoder
- Page 255 and 256:
10 Epimedium Species Sook Peng Yap
- Page 257 and 258:
Epimedium Species 231 A. Genetic Ch
- Page 259 and 260:
Epimedium Species 233 IV. SCIENTIFI
- Page 261 and 262:
Epimedium Species 235 — The immun
- Page 263 and 264:
Epimedium Species 237 osteoporosis.
- Page 265 and 266:
Epimedium Species 239 — E. leptor
- Page 267 and 268:
Epimedium Species 241 H. Cardiovasc
- Page 269 and 270:
Epimedium Species 243 treat yin/yan
- Page 271 and 272:
Epimedium Species 245 31. Liao HJ,
- Page 273 and 274:
11 Ligusticum chuanxiong Hort. Lis
- Page 275 and 276:
Ligusticum chuanxiong Hort. 249 sub
- Page 277 and 278:
Ligusticum chuanxiong Hort. 251 3.
- Page 279 and 280:
Ligusticum chuanxiong Hort. 253 fec
- Page 281 and 282:
Ligusticum chuanxiong Hort. 255 tre
- Page 283 and 284:
Ligusticum chuanxiong Hort. 257 18.
- Page 285:
Ligusticum chuanxiong Hort. 259 50.
- Page 288 and 289:
262 Liu and Ong FIGURE 1 (a) Plant
- Page 290 and 291:
264 FIGURE 2 Continued. Liu and Ong
- Page 292 and 293:
266 Liu and Ong fibrosis (23). The
- Page 294 and 295:
268 Liu and Ong generally support t
- Page 296 and 297:
270 Liu and Ong produced in astrocy
- Page 298 and 299:
272 Liu and Ong tricular contractio
- Page 300 and 301:
274 Liu and Ong (104), mouse perito
- Page 302 and 303:
276 Liu and Ong In accordance with
- Page 304 and 305:
278 Liu and Ong bleomycim, doxorubi
- Page 306 and 307:
280 Liu and Ong 5. Wu WL, Chang WL,
- Page 308 and 309:
282 Liu and Ong mitochondria injury
- Page 310 and 311:
284 Liu and Ong 72. Emson PC. Vasoa
- Page 312 and 313:
286 Liu and Ong 103. Freeman MW. Ma
- Page 314 and 315:
288 Liu and Ong 132. Boyd MR. Bioch
- Page 316 and 317:
290 Ko and Mak FIGURE 1 Chemical st
- Page 318 and 319:
292 Ko and Mak 1 mmol/kg, respectiv
- Page 320 and 321:
294 Ko and Mak cant elevations of d
- Page 322 and 323:
296 Ko and Mak FS extract (63). Dur
- Page 324 and 325:
298 Ko and Mak tert-butyl hydropero
- Page 326 and 327:
300 Ko and Mak GSH to other tissues
- Page 328 and 329:
302 Ko and Mak IV. PHARMACOKINETICS
- Page 330 and 331:
304 Ko and Mak energizing cellular
- Page 332 and 333:
306 Ko and Mak 17. Hikino H, Kiso Y
- Page 334 and 335:
308 Ko and Mak thesis. Hong Kong Un
- Page 336 and 337:
310 Ko and Mak damage to plasma mem
- Page 338 and 339:
312 Ko and Mak 103. Casini AF, Mael
- Page 340 and 341:
314 Ko and Mak Rim H. The effect of
- Page 342 and 343:
316 Sivakami therapeutic properties
- Page 344 and 345:
318 Sivakami one-S-transferase with
- Page 346 and 347:
320 Sivakami matory cell infiltrati
- Page 348 and 349:
322 Sivakami and selenomethionine w
- Page 350 and 351:
324 Sivakami of rats during pregnan
- Page 352 and 353:
326 Sivakami 45. Romay C, Ledon N,
- Page 354 and 355:
328 FIGURE 1 Averrhoa bilimbi leave
- Page 356 and 357:
330 Pushparaj et al. FIGURE 3 The m
- Page 358 and 359:
332 Pushparaj et al. the residual f
- Page 360 and 361:
334 Pushparaj et al. synthetase inh
- Page 362 and 363:
336 medical field. Many have been s
- Page 364 and 365:
338 Yap and Ng little effectiveness
- Page 366 and 367:
340 TABLE 1 Antitumor Properties of
- Page 368 and 369:
342 Yap and Ng FIGURE 2 Electron mi
- Page 370 and 371:
344 Yap and Ng after feedingwith le
- Page 372 and 373:
346 FIGURE 3 Continued. Yap and Ng
- Page 374 and 375:
348 Yap and Ng FIGURE 4 The efficac
- Page 376 and 377:
350 Yap and Ng Lentinan has been us
- Page 378 and 379:
352 Yap and Ng means for serial tra
- Page 380 and 381:
354 study may be to determine the p
- Page 382 and 383:
356 Yap and Ng M, ed. Carbohydrates
- Page 384 and 385:
358 Yap and Ng 57. Hamuro J, Takats
- Page 386 and 387:
360 Yap and Ng oral PSK or LEM admi
- Page 388 and 389:
362 Yap and Ng 115. Dieleman-van Za
- Page 391 and 392:
17 Cruciferous Vegetables and Chemo
- Page 393 and 394:
Cruciferous Vegetables and Chemopre
- Page 395 and 396:
Cruciferous Vegetables and Chemopre
- Page 397 and 398:
Cruciferous Vegetables and Chemopre
- Page 399 and 400:
Cruciferous Vegetables and Chemopre
- Page 401 and 402:
Cruciferous Vegetables and Chemopre
- Page 403 and 404:
Cruciferous Vegetables and Chemopre
- Page 405 and 406:
Cruciferous Vegetables and Chemopre
- Page 407 and 408:
Cruciferous Vegetables and Chemopre
- Page 409 and 410:
Cruciferous Vegetables and Chemopre
- Page 411 and 412:
Cruciferous Vegetables and Chemopre
- Page 413 and 414:
Cruciferous Vegetables and Chemopre
- Page 415 and 416:
Cruciferous Vegetables and Chemopre
- Page 417 and 418:
Cruciferous Vegetables and Chemopre
- Page 419 and 420:
Cruciferous Vegetables and Chemopre
- Page 421 and 422:
Cruciferous Vegetables and Chemopre
- Page 423 and 424:
Cruciferous Vegetables and Chemopre
- Page 425 and 426:
Cruciferous Vegetables and Chemopre
- Page 427 and 428:
Cruciferous Vegetables and Chemopre
- Page 429 and 430:
Cruciferous Vegetables and Chemopre
- Page 431:
Cruciferous Vegetables and Chemopre
- Page 434 and 435:
408 Shi et al. chrysanthemum produc
- Page 436 and 437:
410 Shi et al. and antioxidant acti
- Page 438 and 439:
412 Shi et al. tory effects against
- Page 440 and 441:
414 Shi et al. 1. Antioxidant Activ
- Page 442 and 443:
416 Shi et al. fibrosarcoma induced
- Page 444 and 445:
418 Shi et al. Both apigenin and lu
- Page 446 and 447:
420 Shi et al. in cellular protein
- Page 448 and 449:
422 Shi et al. waf1 and p27/kip1. T
- Page 450 and 451:
424 Shi et al. FIGURE 5 Apoptosis-i
- Page 452 and 453:
426 Shi et al. (77). Pretreatment o
- Page 454 and 455:
428 Shi et al. average intake to a
- Page 456 and 457:
430 effects, including antioxidant,
- Page 458 and 459:
432 Shi et al. 26. Banskota AH, Tez
- Page 460 and 461:
434 Shi et al. 58. Han DH, Tachiban
- Page 462 and 463:
436 Shi et al. 87. Yin F, Giuliano
- Page 464 and 465:
438 Shi et al. 116. Kimata M, Shich
- Page 467 and 468:
19 Andrographis paniculata and the
- Page 469 and 470:
A. paniculata and Cardiovascular Sy
- Page 471 and 472:
A. paniculata and Cardiovascular Sy
- Page 473 and 474:
A. paniculata and Cardiovascular Sy
- Page 475 and 476:
A. paniculata and Cardiovascular Sy
- Page 477 and 478:
A. paniculata and Cardiovascular Sy
- Page 479 and 480:
A. paniculata and Cardiovascular Sy
- Page 481:
A. paniculata and Cardiovascular Sy
- Page 484 and 485:
458 Offord is almost without odor a
- Page 486 and 487:
460 Offord The high antioxidant cap
- Page 488 and 489:
462 Offord effectively induce QR in
- Page 490 and 491:
464 Offord iron was chelated by the
- Page 492 and 493:
466 Offord 14. Houlihan CM, Ho C-T,
- Page 494 and 495:
468 Offord 44. Hayes JD, Pulford DJ
- Page 497 and 498:
21 Crataegus (Hawthorn) Walter K. K
- Page 499 and 500:
Crataegus (Hawthorn) 473 TABLE 2 Se
- Page 501 and 502:
Crataegus (Hawthorn) 475 CoA) reduc
- Page 503 and 504:
Crataegus (Hawthorn) 477 method was
- Page 505 and 506:
Crataegus (Hawthorn) 479 FIGURE 4 E
- Page 507 and 508:
Crataegus (Hawthorn) 481 IV. CARDIO
- Page 509 and 510:
Crataegus (Hawthorn) 483 shows that
- Page 511 and 512:
Crataegus (Hawthorn) 485 4. Rigelsk
- Page 513:
Crataegus (Hawthorn) 487 Differenti
- Page 516 and 517:
490 Pervaiz isolated from the roots
- Page 518 and 519:
492 grape juices. Initial attempts
- Page 520 and 521:
494 Pervaiz (OH ). Excessive accumu
- Page 522 and 523:
496 effects on human cardiovascular
- Page 524 and 525:
498 Pervaiz Koop, 1999). Preincubat
- Page 526 and 527:
500 Pervaiz this regard, an attract
- Page 528 and 529:
502 Pervaiz substances, including c
- Page 530 and 531:
504 Pervaiz production, depending o
- Page 532 and 533:
506 Pervaiz data (K. Ahmad and S. P
- Page 534 and 535:
508 Pervaiz mediated gene expressio
- Page 536 and 537:
510 Pervaiz Goldberg DM, Hahn SE, P
- Page 538 and 539:
512 Pervaiz Kimura Y, Okuda H, Kubo
- Page 540 and 541:
514 Pervaiz Pozo-Guisado E, Alvarez
- Page 543 and 544:
23 Pharmacological and Physiologica
- Page 545 and 546:
Effects of Ginseng 519 FIGURE 1 Str
- Page 547 and 548:
Effects of Ginseng 521 amino-termin
- Page 549 and 550:
Effects of Ginseng 523 as an antica
- Page 551 and 552:
Effects of Ginseng 525 suggest that
- Page 553 and 554:
Effects of Ginseng 527 suggest that
- Page 555 and 556:
Effects of Ginseng 529 studied in c
- Page 557 and 558:
Effects of Ginseng 531 ican ginseng
- Page 559 and 560:
Effects of Ginseng 533 rootlet for
- Page 561 and 562:
Effects of Ginseng 535 65. Duda RB,
- Page 563 and 564:
24 Antioxidant Activities of Prickl
- Page 565 and 566:
Prickly Pear Fruit and Its Betalain
- Page 567 and 568:
Prickly Pear Fruit and Its Betalain
- Page 569 and 570:
Prickly Pear Fruit and Its Betalain
- Page 571 and 572:
Prickly Pear Fruit and Its Betalain
- Page 573 and 574:
Prickly Pear Fruit and Its Betalain
- Page 575 and 576:
Prickly Pear Fruit and Its Betalain
- Page 577 and 578:
Prickly Pear Fruit and Its Betalain
- Page 579 and 580:
Prickly Pear Fruit and Its Betalain
- Page 581 and 582:
Prickly Pear Fruit and Its Betalain
- Page 583 and 584:
25 Antioxidant Activity and Antigen
- Page 585 and 586:
Antioxidant Activity of Cassia tora
- Page 587 and 588:
Antioxidant Activity of Cassia tora
- Page 589 and 590:
Antioxidant Activity of Cassia tora
- Page 591 and 592:
Antioxidant Activity of Cassia tora
- Page 593 and 594:
Antioxidant Activity of Cassia tora
- Page 595 and 596:
Antioxidant Activity of Cassia tora
- Page 597 and 598:
Antioxidant Activity of Cassia tora
- Page 599 and 600:
26 Sho-saiko-to Ichiro Shimizu Toku
- Page 601 and 602:
Sho-saiko-to 575 TABLE 1 Main Activ
- Page 603 and 604:
Sho-saiko-to 577 of much of the col
- Page 605 and 606:
Sho-saiko-to 579 FIGURE 3 Sho-saiko
- Page 607 and 608:
Sho-saiko-to 581 blast-like cells.
- Page 609 and 610:
Sho-saiko-to 583 FIGURE 4 Compariso
- Page 611 and 612:
Sho-saiko-to 585 In a prospective,
- Page 613 and 614:
Sho-saiko-to 587 hepatitis B virus
- Page 615 and 616:
Sho-saiko-to 589 medicine (Sho-saik
- Page 617 and 618:
Sho-saiko-to 591 59. Rockey DC, Hou
- Page 619:
Sho-saiko-to 593 H. Effects of Sho-
- Page 622 and 623:
596 Aviram et al. nalized into the
- Page 624 and 625:
598 Aviram et al. of the cells resp
- Page 626 and 627:
600 Aviram et al. tory, antiallergi
- Page 628 and 629:
602 FIGURE 2 The antioxidative effe
- Page 630 and 631:
604 Aviram et al. moderate reductio
- Page 632 and 633:
606 Aviram et al. tibility of their
- Page 634 and 635:
608 interest is the inverse relatio
- Page 636 and 637:
610 Aviram et al. 23. Aviram M, Mao
- Page 638 and 639:
612 Aviram et al. 55. Aviram M, Ros
- Page 640 and 641:
614 Aviram et al. 84. Fuhrman B, Bu
- Page 642 and 643:
616 Vaya et al. pausal symptoms inc
- Page 644 and 645:
618 Vaya et al. Shiau et al. (23) i
- Page 646 and 647:
620 TABLE 2 Histomorphometric Analy
- Page 648 and 649:
622 The similarity of the glabridin
- Page 650 and 651:
624 Vaya et al. FIGURE 4 The effect
- Page 652 and 653:
626 Vaya et al. hydroxyl 4V may pla
- Page 654 and 655:
628 Vaya et al. absorbing the ultra
- Page 656 and 657:
630 compounds, this knowledge will
- Page 658 and 659:
632 Vaya et al. 29. Lee HP, Gourley
- Page 660 and 661:
634 Vaya et al. 61. Chang AS, Chang
- Page 662 and 663:
636 small molecules and also antiox
- Page 664 and 665:
638 FIGURE 1 Relative antioxidant a
- Page 666 and 667:
640 Konishi et al. cerebral oxidati
- Page 668 and 669:
642 Konishi et al. 3. Halliwell B.
- Page 670 and 671:
644 herbal-based products average a
- Page 672 and 673:
646 Ang At present, researchers at
- Page 674 and 675:
648 Ang eros horn and reindeer antl
- Page 676 and 677:
650 Ang experienced male rodents, p
- Page 678 and 679:
652 Ang 15. Perry LM, ed. Medicinal
- Page 680 and 681:
654 Ang 52. Okano M, Fukamiya N, Le
- Page 682 and 683:
656 Ang 93. Ang HH, Chan KL, Gan EK
- Page 684 and 685:
658 Li and Tsim FIGURE 1 Cordyceps
- Page 686 and 687:
660 Li and Tsim FIGURE 2 (A) The di
- Page 688 and 689:
662 Li and Tsim through food that i
- Page 690 and 691:
664 Li and Tsim campesterol, and di
- Page 692 and 693:
666 Li and Tsim The immune system i
- Page 694 and 695:
668 or normal conditioned medium fr
- Page 696 and 697:
670 carbon-tetrachloride-induced li
- Page 698 and 699:
672 IX. EFFECTS OF CORDYCEPS ON THE
- Page 700 and 701:
674 TABLE 3 The Amounts of Major Ch
- Page 702 and 703:
676 TABLE 4 Pharmacological Activit
- Page 704 and 705:
678 for qualitycontrol of Cordyceps
- Page 706 and 707:
680 Li and Tsim 23. Bok JW, Lermer
- Page 708 and 709:
682 Li and Tsim extracted from Cord
- Page 711 and 712:
32 Phytochemistry, Pharmacology, an
- Page 713 and 714:
Brandisia hancei 687 were character
- Page 715 and 716:
Brandisia hancei 689 In addition, a
- Page 717 and 718:
Brandisia hancei 691 the growth of
- Page 719 and 720:
Brandisia hancei 693 D. Hepatoprote
- Page 721 and 722:
Brandisia hancei 695 mesangial cell
- Page 723 and 724:
Brandisia hancei 697 Acteoside and
- Page 725 and 726:
Brandisia hancei 699 8. Li YM, Han
- Page 727 and 728:
Brandisia hancei 701 42. Xiong Q, H
- Page 729 and 730:
33 Ephedra Christine A. Haller Univ
- Page 731 and 732:
Ephedra 705 attached to the amine t
- Page 733 and 734:
Ephedra 707 cellular membranes in t
- Page 735 and 736:
Ephedra 709 center of the hypothala
- Page 737 and 738:
Ephedra 711 mechanism may cause or
- Page 739 and 740:
Ephedra 713 the significance of the
- Page 741 and 742:
Ephedra 715 free access to alternat
- Page 743 and 744:
Ephedra 717 31. Boozer CN, Daly PA,
- Page 745:
Ephedra 719 67. Gillies H, Derman W
- Page 748 and 749:
722 Mitscher and Cooper fractions.
- Page 750 and 751:
724 Mitscher and Cooper products re
- Page 752 and 753:
726 Mitscher and Cooper There is ev
- Page 754 and 755:
728 FORMULA CHART NO. 2 Cichoric ac
- Page 756 and 757:
730 Mitscher and Cooper FORMULA CHA
- Page 758 and 759:
732 FORMULA CHART NO. 7 Additional
- Page 760 and 761:
734 Mitscher and Cooper deca-8Z,13Z
- Page 762 and 763:
736 FORMULA CHART NO. 9 Echinacea p
- Page 764 and 765:
738 FORMULA CHART NO. 11 Echinacea
- Page 766 and 767:
740 Mitscher and Cooper After 18 hr
- Page 768 and 769:
742 Mitscher and Cooper two extempo
- Page 770 and 771:
744 Mitscher and Cooper were noted
- Page 772 and 773:
746 Mitscher and Cooper no statisti
- Page 774 and 775:
748 Mitscher and Cooper VII. TOXICI
- Page 776 and 777:
750 6. Are the active constituents
- Page 778 and 779:
752 Mitscher and Cooper 33. Johnson
- Page 780 and 781:
754 Mitscher and Cooper 94. Beusche
- Page 782 and 783:
756 Mitscher and Cooper 157. Dorsch
- Page 784 and 785:
758 Klemow et al. H. perforatum has
- Page 786 and 787:
760 Klemow et al. 2.0 cm wide. The
- Page 788 and 789:
762 Klemow et al. FIGURE 2 Structur
- Page 790 and 791:
764 Klemow et al. transmitters like
- Page 792 and 793:
766 Klemow et al. perforatum extrac
- Page 794 and 795:
768 Klemow et al. depression (60,61
- Page 796 and 797:
770 Klemow et al. toxic effects, of
- Page 798 and 799:
772 Klemow et al. referred to those
- Page 800 and 801:
774 Klemow et al. can result in bre
- Page 802 and 803:
776 Klemow et al. 15. Barnes J, And
- Page 804 and 805:
778 Klemow et al. 52. Kim HL, Strel
- Page 806 and 807:
780 Klemow et al. cell growth by hy
- Page 808 and 809:
782 II. ANTICANCER PROPERTIES OF CU
- Page 810 and 811:
784 G. Curcumin Downregulates Cyclo
- Page 812 and 813:
786 III. EFFECT OF CURCUMIN ON ATHE
- Page 814 and 815:
788 Aggarwal et al. fraction had lo
- Page 816 and 817:
790 Aggarwal et al. cium ionophore
- Page 818 and 819:
792 Aggarwal et al. which may have
- Page 820 and 821:
794 VI. CURCUMIN ENHANCES WOUND HEA
- Page 822 and 823:
796 Aggarwal et al. the WGA-bound f
- Page 824 and 825:
798 Aggarwal et al. derivative exhi
- Page 826 and 827:
800 Aggarwal et al. days. At variou
- Page 828 and 829:
802 Aggarwal et al. cholesterol. Cu
- Page 830 and 831:
804 Aggarwal et al. 9. Limtrakul P,
- Page 832 and 833:
806 Aggarwal et al. sis: role of nu
- Page 834 and 835:
808 Aggarwal et al. 69. Adelaide J,
- Page 836 and 837:
810 Aggarwal et al. 100. Srinivasan
- Page 839 and 840:
37 Extracts from the Leaves of Chro
- Page 841 and 842:
Chromolaena odorata Extract 815 II.
- Page 843 and 844:
Chromolaena odorata Extract 817 E.
- Page 845 and 846:
Chromolaena odorata Extract 819 FIG
- Page 847 and 848:
Chromolaena odorata Extract 821 FIG
- Page 849 and 850:
Chromolaena odorata Extract 823
- Page 851 and 852:
Chromolaena odorata Extract 825 FIG
- Page 853 and 854:
Chromolaena odorata Extract 827 and
- Page 855 and 856:
Chromolaena odorata Extract 829 FIG
- Page 857 and 858:
Chromolaena odorata Extract 831 p-H
- Page 859 and 860:
Chromolaena odorata Extract 833 the
- Page 861 and 862:
Chromolaena odorata Extract 835 Cha
- Page 863 and 864:
38 Medicinal Properties of Eucommia
- Page 865 and 866:
Medicinal Properties of Eucommia 83
- Page 867 and 868:
Medicinal Properties of Eucommia 84
- Page 869 and 870:
Medicinal Properties of Eucommia 84
- Page 871:
Medicinal Properties of Eucommia 84
- Page 874 and 875:
848 popular forms of all complement
- Page 876 and 877:
850 IV. GINKGO (GINKGO BILOBA) Erns
- Page 878 and 879:
852 Ernst such cases had been repor
- Page 880 and 881:
854 ing overall result. There is no
- Page 883 and 884:
40 Use of Silicon-Based Oligonucleo
- Page 885 and 886:
Si-Based Chip to Authenticate TCM 8
- Page 887 and 888:
Si-Based Chip to Authenticate TCM 8
- Page 889 and 890:
Si-Based Chip to Authenticate TCM 8
- Page 891 and 892:
Si-Based Chip to Authenticate TCM 8
- Page 893 and 894:
Si-Based Chip to Authenticate TCM 8
- Page 895 and 896:
Si-Based Chip to Authenticate TCM 8
- Page 897:
Si-Based Chip to Authenticate TCM 8
- Page 900 and 901:
874 Halliwell selected plant extrac
- Page 902 and 903:
876 organ damage can also occur. In
- Page 904 and 905:
878 arsenic, cadmium, and selenium
- Page 906 and 907:
880 Halliwell 6. Ames BW, Gold LS.
- Page 909 and 910:
42 Review of Adverse Effects of Chi
- Page 911 and 912:
Adverse Effects of CHM 885 When a c
- Page 913 and 914:
Adverse Effects of CHM 887 D. Chans
- Page 915 and 916:
Adverse Effects of CHM 889 A. Aconi
- Page 917 and 918:
Adverse Effects of CHM 891 VI. HERB
- Page 919 and 920:
Adverse Effects of CHM 893 A molecu
- Page 921 and 922:
Adverse Effects of CHM 895 2C19, 3A
- Page 923 and 924:
Adverse Effects of CHM 897 23. Vogl
- Page 925 and 926:
Adverse Effects of CHM 899 Brown MB
- Page 927:
Adverse Effects of CHM 901 miltiorr
- Page 930 and 931:
904 [Adverse effects] schisandrin B
- Page 932 and 933:
906 Antiplatlet effects, 253, 529-5
- Page 934 and 935:
908 [Cardiovascular system effects]
- Page 936 and 937:
910 Cherry, George W., 813-836 Ches
- Page 938 and 939:
912 [Cruciferous vegetables (Brassi
- Page 940 and 941:
914 [Echinacea (Echinacea augustifo
- Page 942 and 943:
916 [Future perspectives] SMS (Shen
- Page 944 and 945:
918 Heavy metal contamination, 889-
- Page 946 and 947:
920 Illustrations, herbs. See also
- Page 948 and 949:
922 Lentinus edodes, 355-363. See a
- Page 950 and 951:
924 [Ma huang (Ephedra species)] re
- Page 952 and 953:
926 [Overviews] Chromolaena odorata
- Page 954 and 955:
928 [Prickly pear (Opuntia ficus in
- Page 956 and 957:
930 Regulatory and policy issues, 8
- Page 958 and 959:
932 [Scrophulariaceae (Brand hancei
- Page 960 and 961:
934 Systematic reviews, 847-855. Se
- Page 962 and 963:
936 [Therapeutic uses] antidiabetic
- Page 964 and 965:
938 [Therapeutic uses] mycovirus pr
- Page 966 and 967:
940 Traditional Chinese medicine. S